Dupuytren's Disease
25
6
6
14
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
4.0%
1 terminated out of 25 trials
93.3%
+6.8% vs benchmark
28%
7 trials in Phase 3/4
50%
7 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (25)
Efficacy of Aponeurectomy on the 2-year Recurrence Rate of Dupuytren's Disease
MiniFlo for Advanced Dupuytren's Disease
Post-contracture Release Radiation for Dupuytren's Disease
Micronerves in Dupuytren and the Impact of Its Dissection on Recurrence
Palmaris Longus Muscle and Dupuytren
Prognostic Profile of Dupuytren's Disease: a Cohort Study (PRODUCT)
Goniometry and Goniometric Measurement on Standardised Images in Dupuytren's Disease
Nodular Shrinking in Dupuytren Disease
Effectiveness of Splinting After Collagenase Injection
Repurposing Anti-TNF for Treating Dupuytren's Disease
Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture
Evaluation of Xiaflex: Trial of Effectivenss iN Dupuytren's
Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture
Effectiveness of a Tele-Rehabilitation Evidence-based Tablet App for Rehabilitation in Traumatic Bone and Soft Injuries of the Hand, Wrist and Fingers.
Tolerance and Efficacy Study of Second-line Surgery After Percutaneous Needle Aponeurotomy for Dupuytren's Disease.
Retreatment of Recurrent Dupuytren's Contractures
Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules
MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex
Registry of Dupuytren's Contracture Treatment Outcomes
Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859